TSC Staff
Meanwhile, investors drove Discovery Labs (DSCO Quote - Cramer on DSCO - Stock Picks) up 13% to $2.76, as the company awaits an FDA decision -- expected on or before Thursday -- on its Surfaxin as a treatment for premature infants suffering from respiratory distress. Manufacturing and quality control issues have stymied two previous stabs at approval.
Computer systems maker RadiSys (RSYS Quote - Cramer on RSYS - Stock Picks) shot up 21% to $9.83. The Hillsboro, Ore.-based firm announced non-GAAP first-quarter income of $57,000, or breakeven a share, for the first quarter, vs. a profit of $702,000, or 3 cents a share, a year ago. Analysts polled by Thomson Financial were looking for a per-share loss of a penny. The company also forecast non-GAAP second-quarter EPS between 6 cents and 11 cents. The Street is looking for earnings at the low end of that range.
Featured Photo Galleries
Sign up for our FREE newsletters now.
See All
Sponsored by:
Get Cramer's portfolio stock picks at Action Alerts PLUS — 
RSS
